CAPTRUST Financial Advisors’s Emergent Biosolutions EBS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$84.9K Buy
+10,137
New +$84.8K ﹤0.01% 3071
2022
Q3
Sell
-2,772
Closed -$86K 2610
2022
Q2
$86K Buy
2,772
+906
+49% +$30.9K ﹤0.01% 2319
2022
Q1
$77K Sell
1,866
-70
-4% -$3.09K ﹤0.01% 2465
2021
Q4
$84K Buy
1,936
+602
+45% +$27.2K ﹤0.01% 2295
2021
Q3
$67K Sell
1,334
-132
-9% -$7.99K ﹤0.01% 2374
2021
Q2
$92K Sell
1,466
-171
-10% -$11K ﹤0.01% 2092
2021
Q1
$152K Sell
1,637
-2,218
-58% -$227K ﹤0.01% 1666
2020
Q4
$345K Buy
3,855
+3,500
+986% +$321K ﹤0.01% 959
2020
Q3
$38K Sell
355
-2,410
-87% -$260K ﹤0.01% 1727
2020
Q2
$226K Buy
+2,765
New +$206K ﹤0.01% 978
2019
Q4
Sell
-219
Closed -$11K 1219
2019
Q3
$11K Sell
219
-87
-28% -$4.05K ﹤0.01% 1461
2019
Q2
$15K Buy
306
+230
+303% +$11K ﹤0.01% 1368
2019
Q1
$4K Buy
76
+34
+81% +$2.01K ﹤0.01% 1570
2018
Q4
$2K Buy
+42
New +$2.71K ﹤0.01% 1478

Other funds holding EBS

CAPTRUST Financial Advisors's EBS Position: Q2 2026 in Review

CAPTRUST Financial Advisors opened a new position in Emergent Biosolutions (EBS) in Q2 2026: 10,137 shares worth $84.9K. The stake represents ﹤0.01% of the portfolio and ranks #3071 among its holdings. This is a return to the name: CAPTRUST Financial Advisors previously reported a position in EBS as recently as Q2 2022.

CAPTRUST Financial Advisors first reported a position in EBS in Q4 2018 and has held it in 14 quarters since. The position peaked at $345K in Q4 2020. 195 funds tracked by Wall St. Rank hold EBS as of Q2 2026.

  • CAPTRUST Financial Advisors held 10,137 shares of Emergent Biosolutions worth $84.9K as of Q2 2026.
  • Emergent Biosolutions was a new CAPTRUST Financial Advisors position in Q2 2026.
  • Emergent Biosolutions made up ﹤0.01% of CAPTRUST Financial Advisors's portfolio in Q2 2026, its #3071 holding.
  • CAPTRUST Financial Advisors first reported a position in Emergent Biosolutions in Q4 2018 and has held it in 14 quarters since.
  • CAPTRUST Financial Advisors's Emergent Biosolutions position peaked at $345K in Q4 2020.
  • 195 funds tracked by Wall St. Rank held Emergent Biosolutions as of Q2 2026.

Based on CAPTRUST Financial Advisors's 13F filing for Q2 2026, filed 13 Aug 2026.